Navigation Links
Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
Date:6/19/2008

AstraZeneca's CEO to be Deposed in London on Friday, June 20, 2008

NEW YORK, June 19 /PRNewswire/ -- Weitz & Luxenberg, PC, one of the leading plaintiffs' litigation law firms in America, filed a lawsuit today against pharmaceutical giant AstraZeneca on behalf of a New York City Fire Department Emergency Medical Technician whose diabetes was allegedly caused by AstraZeneca's drug Seroquel. The plaintiff, EMT Ernest Armstead, was one of the many brave responders on the morning of September 11, 2001. He was severely injured when the World Trade Center's North Tower collapsed as he was helping victims at the foot of the buildings.

Suffering from Post-Traumatic Stress Disorder after recovery from his 9/11 physical injuries, Mr. Armstead was prescribed Seroquel, which Weitz & Luxenberg claims did not carry a warning that the powerful drug can cause diabetes. He thereafter developed the debilitating, life-long disease known as Type 2 diabetes. Mr. Armstead joins thousands of others across the country who has filed actions claiming that Seroquel caused them to develop diabetes and that AstraZeneca hid its knowledge of this risk from the FDA, doctors and patients.

In a letter dated November 16, 2006, the Department of Health and Human Services of the Food and Drug Administration cited violations of the Federal Food, Drug, and Cosmetic Act in connection with AstraZeneca's use of promotional material deemed by the FDA to be "false or misleading because it minimizes the risk of hyperglycemia and diabetes mellitus" and which "raises significant public health and safety concerns through its minimization of the risks associated with Seroquel."

A deposition of AstraZeneca's Chief Executive Officer, David Brennan, about his company's alleged undisclosed knowledge regarding the dangerous side effect of diabetes, is being taken this Friday, June 20th in London, England at the law offices of Baker Botts, a U.S. firm defending the company. Lawyers fr
'/>"/>

SOURCE Weitz & Luxenberg, PC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Genzyme Files Applications for Approval of Mozobil in the United States and Europe
2. Jazz Pharmaceuticals Files Form S-3 Registration Statements
3. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
4. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
5. Immunosyn Corporation Files 10-Q
6. Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance
7. Benda Pharmaceutical Files Amendment To Form S-1
8. Oncothyreon files investigational new drug application for PX-866 oncology compound
9. Vion Pharmaceuticals Files Plan With Nasdaq
10. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
11. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the Company" or "RegeneRx") today ... on Thymosins in Health and Disease in ... beta 4 (TB4) linked with rhodamine (a fluorescent tracer ... rodent model of stroke, it was visualized outside of ... tissue of the brain).   The leakage of TB4 in ...
(Date:10/25/2014)... 2014 ... announced the addition of the  "The Global ... 2-D Nanomaterials "  report to their offering.  ... and graphene are the strongest, lightest and ... a performance-per-weight greater than any other material. ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... Shimadzu Scientific Instruments introduces its Open Solution ... pain management and clinical markets. The software increases the ... allowing users to highlight and review results that are ... analysts to filter results by group or based on ... the need to sift through analytes of no interest. ...
Breaking Biology Technology:Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2
... ST. LOUIS, Oct. 16 SAFC Supply ... the Sigma-Aldrich(TM) group (Nasdaq:,SIAL), has announced that ... are now available within its extensive Flavors ... . The Halal certification follows a ...
... data on mass spectrometry are presented in the ... from ortho-, meta-, and para-hydroxyphenyl carbaldehydes, ketones, and ... his colleagues in the Center for Mass Spectrometry ... to a study, Collision-induced dissociation (CID) mass spectra ...
... NEW YORK, Oct. 15 Senex Biotechnology, Inc. ... at the 8th International,Conference on Alzheimer,s Disease Drug ... of Senex, described the identification of the first,drug ... amounts of,several proteins involved in Alzheimer,s disease, including: ...
Cached Biology Technology:Halal-Certified Products Introduced Into SAFC Supply Solutions' Flavors & Fragrances Food-Grade Line 2Halal-Certified Products Introduced Into SAFC Supply Solutions' Flavors & Fragrances Food-Grade Line 3Stevens researchers provide new information about mass spectrometry 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 3
(Date:10/17/2014)... German . To ... treating overdoses, doctors are often limited to supportive therapy such ... a combination of drugs involved. So what can be done ... pills? ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical ... this question. "The task was to develop an agent that ...
(Date:10/16/2014)... conventional thinking on how the bowel lining develops and, ... bowel cancer starts. , The researchers produced evidence that ... ,crypts, that are a feature of the bowel lining, ... cancer development, a controversial finding as scientists are still ... imaging technologies, Dr Chin Wee Tan and Professor Tony ...
(Date:10/16/2014)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market announces that ... Smart Wallet, at the 13 th annual Future ... conference on the intersection of technology and the economy. ... founder and publisher of the Strategic News Service™, the ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Cryptic clues drive new theory of bowel cancer development 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... about river morphology in Oregon; coastal responses to ... sequestration; fault systems in the Blue Mountains of ... Bighorn Arch, Wyoming; high-diversity plant fossil assemblages of ... Interior Seaway; stratigraphy in Italy; the Soreq drainage, ...
... development, all cells turn off genes they don,t need, often ... process called methylation. Historically, scientists believed methyl groups could only ... a guanine, called CpG. But in recent years, they have ... been found in stem cells, and in neurons in the ...
... studies of its type has found that a startling 59 ... insecure" at some point during the previous year, with possible ... issues. Contrary to concerns about obesity and some students ... is that many students are not getting enough healthy food ...
Cached Biology News:GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 2GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 3GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 4GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 5GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 6GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 7GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 8GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 9GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 10GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 11GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 12GSA Bulletin covers the US, Italy, Iran, Jamaica, Chile, and Argentina, and China 13Permanent changes in brain genes may not be so permanent after all 2Study identifies high level of 'food insecurity' among college students 2Study identifies high level of 'food insecurity' among college students 3
... mutS and ES1301 mutS are mismatch repair ... these strains prevents repair of the newly ... mutation efficiencies and making them helpful in ... Sites II Mutagenesis Systems. Both ES1301 and ...
Request Info...
Anti-Rat KAPPA/LAMBDA:HRP, Clone MARK-1/MARL-15, Monoclonal Antibody...
For the development of an immunoprecipitation assay to measure Chk1 kinase activity in cell lysates....
Biology Products: